BPC-157 (Pentadecapeptide)

Growth Factor Signalling in the BPC-157 Literature

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

Reported interactions with growth-factor signalling form part of BPC-157's multi-pathway description, including effects related to growth hormone receptor expression in tendon fibroblast work. Without an identified receptor for the peptide itself, these remain observations rather than a mapped mechanism.

Key facts

Reported
Effects on growth-factor signalling
Context
Tendon fibroblast and repair models
Peptide receptor
None identified
Interpretation
Downstream observation, not initiating event
Evidence type
In vitro and rodent
Independent replication
Limited

What is reported

Work in tendon fibroblast systems has reported effects related to growth hormone receptor expression, and the broader literature describes interactions with growth-factor signalling more generally. These sit within the multi-pathway framing rather than constituting a separate mechanism.

The interpretive problem

An effect on growth-factor signalling can be an initiating event or a downstream consequence of something else entirely. Distinguishing them requires knowing where the compound acts first, and no receptor for BPC-157 has been identified. Without that anchor, a reported change in a signalling pathway is a position in a chain of unknown length rather than a starting point.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £16.95

Why this recurs across the category

It is the same limitation described in the mechanism article, appearing again in a specific context. Every mechanistic finding for BPC-157 has the same shape: a measurable effect on a known pathway, with no established route from the peptide to that pathway. The findings accumulate without converging.

How growth-factor claims should be read

Growth-factor language carries strong connotations of tissue building and repair, and it is easy for a reported interaction to be presented as a demonstrated growth effect. The reported observations concern signalling components in model systems. They are not evidence of growth, repair or regeneration in an organism.

What would change the picture

A molecular target for the peptide. That would convert every downstream observation from a floating association into a position in a defined pathway, and would make the growth-factor findings interpretable. It remains the single most valuable missing piece in this compound's characterisation.

Frequently asked questions

Does BPC-157 act on growth hormone receptors?

Effects related to growth hormone receptor expression have been reported in tendon fibroblast work. Whether that is an initiating event or downstream of something else is not established.

Why is the absence of a receptor such a problem?

Without knowing where the compound acts first, any downstream finding is a position in a chain of unknown length rather than a mechanism.

Does this mean BPC-157 promotes growth?

No. The observations concern signalling components in model systems, not growth or repair in an organism.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More BPC-157 (Pentadecapeptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.